Impact of bisphosphonate use on the risk of atrial fibrillation in patients with cardiovascular disease

被引：0
|
作者：
Barnes, Brian J. [1 ]
Howard, Patricia A. [1 ]
Chen, Warren [1 ]
Vacek, James L. [1 ]
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
来源：
CIRCULATION | 2008年 / 117卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
33
引用
收藏
页码：E417 / E417
页数：1
相关论文
共 50 条
  • [41] Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease Atrial Fibrillation
    Winkelmayer, Wolfgang C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (09): : 1423 - 1425
  • [42] Left atrial appendage closure devices for cardiovascular risk reduction in atrial fibrillation patients
    Cruz-Gonzalez, Ignacio
    Carlos Rama-Merchan, Juan
    Rodriguez-Collado, Javier
    Martin-Moreiras, Javier
    Diego-Nieto, Alejandro
    Arribas-Jimenez, Antonio
    Luis Sanchez, Pedro
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2015, 6 : 47 - 56
  • [43] Incident Atrial Fibrillation and Cardiovascular Risk Increases in Patients With Increased Burden of Atrial Ectopy
    Sattin, Michael N.
    Li Zhe
    Mrkobrada, Marko
    Spicer, Erin, I
    STROKE, 2021, 52
  • [44] OPTIMAL BLOOD PRESSURE AND CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH ATRIAL FIBRILLATION
    Lip, Gregory
    JOURNAL OF HYPERTENSION, 2023, 41 : E32 - E32
  • [45] PREVALENCE OF NOVEL CARDIOVASCULAR RISK FACTORS IN HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATION
    Platek, A. E.
    Szymanski, F. M.
    Filipiak, K. J.
    Kotkowski, M.
    Opolski, G.
    JOURNAL OF HYPERTENSION, 2015, 33 : E144 - E144
  • [46] Evaluation of atrial fibrillation management and cardiovascular risk profile in atrial fibrillation patients: A cross-sectional survey
    Rackauskas, Gediminas
    Zabiela, Vytautas
    Marinskis, Germanas
    Baranauskas, Arvydas
    Balkute, Deimile
    Alunderyte, Justina
    Puodziukynas, Aras
    Kazakevicius, Tomas
    Kviesulaitis, Vilius
    Aidietis, Audrius
    MEDICINA-LITHUANIA, 2017, 53 (01): : 19 - 25
  • [47] Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk
    Stuehlinger, Markus C.
    Weltermann, Ansgar
    Staber, Philipp
    Heintel, Daniel
    Noesslinger, Thomas
    Steurer, Michael
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (3-4) : 97 - 109
  • [48] Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation
    Hijazi, Ziad
    Aulin, Julia
    Andersson, Ulrika
    Alexander, John H.
    Gersh, Bernard
    Granger, Christopher B.
    Hanna, Michael
    Horowitz, John
    Hylek, Elaine M.
    Lopes, Renato D.
    Siegbahn, Agneta
    Wallentin, Lars
    HEART, 2016, 102 (07) : 508 - 517
  • [49] Atrial fibrillation: selecting patients at risk for cardiovascular events by blood pressure
    Millenaar, Dominic
    Boehm, Michael
    EUROPEAN HEART JOURNAL, 2020, 41 (48) : 4600 - 4600
  • [50] Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study
    Erichsen, R.
    Christiansen, C. F.
    Froslev, T.
    Jacobsen, J.
    Sorensen, H. T.
    BRITISH JOURNAL OF CANCER, 2011, 105 (07) : 881 - 883
12345